Quince Therapeutics Inc (QNCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,980 | -12,476 | -12,235 | N/A | N/A |
| Depreciation Amortization | -624 | -300 | 45 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,580 | -23 | 223 | N/A | N/A |
| Other Working Capital | 1,904 | -390 | 460 | N/A | N/A |
| Other Operating Activity | -157 | 1,494 | 1,680 | 0 | 0 |
| Operating Cash Flow | $-33,277 | $-11,695 | $-9,827 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -17,692 | -46,542 | N/A | N/A | N/A |
| PPE Investments | -55 | -212 | -77 | N/A | N/A |
| Investing Cash Flow | $-17,747 | $-46,754 | $-77 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 250 | 7,750 | N/A | N/A |
| Debt Repayment | -559 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 77,925 | 24 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 75,654 | 0 | 0 | 0 |
| Financing Cash Flow | $77,366 | $75,928 | $7,750 | $N/A | $N/A |
| Beginning Cash Position | 24,872 | 7,393 | 9,547 | N/A | N/A |
| End Cash Position | 51,214 | 24,872 | 7,393 | N/A | N/A |
| Net Cash Flow | $26,342 | $17,479 | $-2,154 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,277 | -11,695 | -9,827 | N/A | N/A |
| Capital Expenditure | -55 | -212 | -77 | N/A | N/A |
| Free Cash Flow | -33,332 | -11,907 | -9,904 | 0 | 0 |